{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:11:34Z","timestamp":1793423494218,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ARES-CCD","award":["PRD2013-SOUOPGUI"],"award-info":[{"award-number":["PRD2013-SOUOPGUI"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2944-z","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T06:46:18Z","timestamp":1529390778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon"],"prefix":"10.1186","volume":"11","author":[{"given":"Guy-Roger","family":"Kamga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny N.","family":"Dissak-Delon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues C.","family":"Nana-Djeunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Biholong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Mbigha","family":"Ghogomu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Souopgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kamgno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"2944_CR1","first-page":"505","volume":"91","author":"WHO","year":"2016","unstructured":"WHO. Progress report on the elimination of human onchocerciasis, 2015\u20132016. Wkly Epidemiol Rec. 2016;91:505\u201314.","journal-title":"Wkly Epidemiol Rec."},{"key":"2944_CR2","first-page":"681","volume":"92","author":"WHO","year":"2017","unstructured":"WHO. Progress report on the elimination of human onchocerciasis, 2016\u20132017. Wkly Epidemiol Rec. 2017;92:681\u201394.","journal-title":"Wkly Epidemiol Rec."},{"key":"2944_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005424","volume":"11","author":"JR Herricks","year":"2017","unstructured":"Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Bas\u00e1\u00f1ez M-G, et al. The global burden of disease study 2013: what does it mean for the NTDs? PLoS Negl Trop Dis. 2017;11:e0005424.","journal-title":"PLoS Negl Trop Dis."},{"key":"2944_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0001-706X(91)90015-C","volume":"48","author":"AP Plaisier","year":"1991","unstructured":"Plaisier AP, van Oortmarssen GJ, Remme J, Habbema JD. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop. 1991;48:271\u201384.","journal-title":"Acta Trop."},{"key":"2944_CR5","first-page":"61","volume":"44","author":"BO Duke","year":"1993","unstructured":"Duke BO. The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol. 1993;44:61\u20138.","journal-title":"Trop Med Parasitol."},{"key":"2944_CR6","unstructured":"WHO-TDR. The involvement of community-directed distributors of ivermectin in other health and development activities-Report of a multi-country study. Geneva: World Health Organization; 2003. \n                    http:\/\/www.who.int\/tdr\/publications\/tdr-research-publications\/ivermect_distrib\/en\/\n                    \n                  ."},{"key":"2944_CR7","volume-title":"Community-directed interventions for major health problems in Africa - a multi-country study:final report 2008","author":"WHO-TDR","year":"2008","unstructured":"WHO-TDR. Community-directed interventions for major health problems in Africa - a multi-country study:final report 2008. \n                    http:\/\/www.who.int\/tdr\/publications\/tdr-research-publications\/community-directed-interventions-health-problems\/en\/\n                    \n                  . Geneva: World Health Organization; 2008."},{"key":"2944_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/inthealth\/ihv038","volume":"8","author":"MN Katabarwa","year":"2016","unstructured":"Katabarwa MN, Habomugisha P, Eyamba A, Byamukama E, Nwane P, Arinaitwe A, et al. Community-directed interventions are practical and effective in low-resource communities: experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004\u20132010. Int Health. 2016;8:116\u201323.","journal-title":"Int Health."},{"key":"2944_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40249-016-0160-7","volume":"5","author":"AH Tekle","year":"2016","unstructured":"Tekle AH, Zoure HG, Noma M, Boussinesq M, Coffeng LE, Stolk WA, Remme JH. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results. Infect Dis Poverty. 2016;5:66.","journal-title":"Infect Dis Poverty."},{"key":"2944_CR10","unstructured":"GTNO-Cameroun. Rapport technique annuel 2014; 2015. Unpublished"},{"key":"2944_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1756-3305-4-152","volume":"4","author":"WR Brieger","year":"2011","unstructured":"Brieger WR, Okeibunor JC, Abiose AO, Wanji S, Elhassan E, Ndyomugyenyi R, Amazigo UV. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria. Parasit Vectors. 2011;4:152.","journal-title":"Parasit Vectors."},{"key":"2944_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-3305-3-48","volume":"3","author":"D Yirga","year":"2010","unstructured":"Yirga D, Deribe K, Woldemichael K, Wondafrash M, Kassahun W. Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in southwestern Ethiopia. Parasit Vectors. 2010;3:48.","journal-title":"Parasit Vectors."},{"key":"2944_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4314\/eamj.v83i6.9440","volume":"83","author":"TL Lakwo","year":"2006","unstructured":"Lakwo TL, Gasarasi DB. Non-adherence to community directed treatment with ivermectin for onchocerciasis control in Rungwe District, southwest Tanzania. East Afr Med J. 2006;83:326\u201332.","journal-title":"East Afr Med J."},{"key":"2944_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1179\/136485905X24201","volume":"99","author":"NB Semiyaga","year":"2005","unstructured":"Semiyaga NB, Lalobo O, Ndyomugyenyi R. Refusal to take ivermectin: the associated 'risk' factors in Hoima district, Uganda. Ann Trop Med Parasitol. 2005;99:165\u201372.","journal-title":"Ann Trop Med Parasitol."},{"key":"2944_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-3156.2005.01436.x","volume":"10","author":"F Nuwaha","year":"2005","unstructured":"Nuwaha F, Okware J, Ndyomugyenyi R. Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results. Trop Med Int Health. 2005;10:659\u201367.","journal-title":"Trop Med Int Health."},{"key":"2944_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/420928","volume":"2013","author":"MN Katabarwa","year":"2013","unstructured":"Katabarwa MN, Eyamba A, Nwane P, Enyong P, Kamgno J, Kuete T, et al. Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon. J Parasitol Res. 2013;2013:420928.","journal-title":"J Parasitol Res."},{"key":"2944_CR17","volume-title":"Training for Mid-Level Managers: The EPI Coverage Survey. WHO\/IVB\/08.07 WHO\/EPI\/MLM","author":"WHO","year":"2008","unstructured":"WHO. Training for Mid-Level Managers: The EPI Coverage Survey. WHO\/IVB\/08.07 WHO\/EPI\/MLM. Geneva: World Health Organization; 2008."},{"key":"2944_CR18","unstructured":"WHO. Immunization Coverage Cluster Survey- Reference Manual. WHO\/IVB\/04.23; Geneva: World Health Organization; 2005."},{"key":"2944_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4269\/ajtmh.2012.12-0167","volume":"87","author":"C Worrell","year":"2012","unstructured":"Worrell C, Mathieu E. Drug coverage surveys for neglected tropical diseases: 10 years of field experience. Am J Trop Med Hyg. 2012;87:216\u201322.","journal-title":"Am J Trop Med Hyg."},{"key":"2944_CR20","unstructured":"BUCREP. Projections d\u00e9mographiques du troisi\u00e8me Recensement G\u00e9n\u00e9ral de la Population et de l\u2019Habitat (3\u00e8me RGPH) du Cameroun; 2010. \n                    http:\/\/www.bucrep.cm\/index.php\/fr\/ressources-et-documentations\/telechargement\/category\/82-projections-demographiques\n                    \n                  ."},{"key":"2944_CR21","doi-asserted-by":"publisher","DOI":"10.1201\/9781420080674","volume-title":"Applied survey data analysis","author":"SG Heeringa","year":"2010","unstructured":"Heeringa SG, West BT, Berglund PA. Applied survey data analysis. Boca Raton, FL: Chapman and Hall; 2010."},{"key":"2944_CR22","volume-title":"Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: A manual for national elimination programmes","author":"WHO","year":"2011","unstructured":"WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: A manual for national elimination programmes. Geneva: World Health Organization; 2011."},{"key":"2944_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7:e2447.","journal-title":"PLoS Negl Trop Dis"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-016-1311-1","volume":"9","author":"KV Shuford","year":"2016","unstructured":"Shuford KV, Turner HC, Anderson RM. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors. 2016;9:29.","journal-title":"Parasit Vectors."},{"key":"2944_CR25","volume-title":"Coverage evaluation surveys for preventive chemotherapy: field guide for implementation","author":"WHO","year":"2016","unstructured":"WHO. Coverage evaluation surveys for preventive chemotherapy: field guide for implementation; 2016."},{"key":"2944_CR26","volume-title":"Community-directed treatment with ivermectin (cdti): a practical guide for trainers of community-directed distributors","author":"WHO\/APOC","year":"1998","unstructured":"WHO\/APOC. Community-directed treatment with ivermectin (cdti): a practical guide for trainers of community-directed distributors. Geneva: World Health Organization; 1998."},{"key":"2944_CR27","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.socscimed.2007.01.018","volume":"64","author":"U Amazigo","year":"2007","unstructured":"Amazigo U, Okeibunor J, Matovu V, Zoure H, Bump J, Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med. 2007;64:2070\u201382.","journal-title":"Soc Sci Med."},{"key":"2944_CR28","doi-asserted-by":"crossref","unstructured":"Mbanefo EC, Eneanya CI, Nwaorgu OC, Oguoma VM, Otiji MO, Ogolo BA. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI). Postgrad Med J. 2010;86:573\u20137.","DOI":"10.1136\/pgmj.2010.100248"},{"key":"2944_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1478-4505-10-16","volume":"10","author":"SE Meredith","year":"2012","unstructured":"Meredith SE, Cross C, Amazigo UV. Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda. Health Res Policy Syst. 2012;10:16.","journal-title":"Health Res Policy Syst."},{"key":"2944_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004905","volume":"10","author":"L Senyonjo","year":"2016","unstructured":"Senyonjo L, Oye J, Bakajika D, Biholong B, Tekle A, Boakye D, et al. Factors associated with ivermectin non-compliance and its potential role in sustaining Onchocerca volvulus transmission in the west region of cameroon. PLoS Negl Trop Dis. 2016;10:e0004905.","journal-title":"PLoS Negl Trop Dis."},{"key":"2944_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13071-017-2301-7","volume":"10","author":"GR Kamga","year":"2017","unstructured":"Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, et al. Important progress towards elimination of onchocerciasis in the West region of Cameroon. Parasit Vectors. 2017;10:373.","journal-title":"Parasit Vectors."},{"key":"2944_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005849","volume":"11","author":"FN Dissak-Delon","year":"2017","unstructured":"Dissak-Delon FN, Kamga GR, Humblet PC, Robert A, Souopgui J, Kamgno J, et al. Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs. PLoS Negl Trop Dis. 2017;11:e0005849.","journal-title":"PLoS Negl Trop Dis."},{"key":"2944_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s13071-016-1868-8","volume":"9","author":"GR Kamga","year":"2016","unstructured":"Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Mbigha-Ghogomu S, Souopgui J, et al. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment. Parasit Vectors. 2016;9:581.","journal-title":"Parasit Vectors."},{"key":"2944_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-3156.2006.01796.x","volume":"12","author":"WR Brieger","year":"2007","unstructured":"Brieger WR, Okeibunor JC, Abiose AO, Ndyomugyenyi R, Kisoka W, Wanji S, et al. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control. Trop Med Int Health. 2007;12:260\u20138.","journal-title":"Trop Med Int Health."},{"key":"2944_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s13071-015-1283-6","volume":"8","author":"S Wanji","year":"2015","unstructured":"Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PW, Adzemye BF, Eyong JE, et al. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon. Parasit Vectors. 2015;8:667.","journal-title":"Parasit Vectors."},{"key":"2944_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004358","volume":"10","author":"PJ Budge","year":"2016","unstructured":"Budge PJ, Sognikin E, Akosa A, Mathieu EM, Deming M. Accuracy of coverage survey recall following an integrated mass drug administration for lymphatic filariasis, schistosomiasis, and soil-transmitted helminthiasis. PLoS Negl Trop Dis. 2016;10:e0004358.","journal-title":"PLoS Negl Trop Dis."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2944-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:30:16Z","timestamp":1560886216000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2944-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2944-z","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethical clearance was obtained from the National Ethics Committee for Human Health Research (N\u00b02015\/01\/543\/CE\/CNRESH\/SP) and an administrative authorization was granted by the Cameroon Ministry of Public Health (N\u00b0631-1315) prior to the beginning of the surveys. The study was also approved by the Ethics committee of the Medical Faculty of Universit\u00e9 Catholique de Louvain, Belgium. The objectives and schedules of the study were explained to health district management teams, the community leaders, the community drug distributors and to all heads of households selected before requesting a verbal agreement to participate. Participation was entirely voluntary and any individual (or parent of a child) was free to opt out without fear of retaliation from their community leaders and programme personnel.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"356"}}